Logo image of SHL.DE

SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock

44.92 EUR
+0.24 (+0.54%)
Last: 12/30/2025, 2:06:15 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 62 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SHL was profitable.
In the past year SHL had a positive cash flow from operations.
Each year in the past 5 years SHL has been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
SHL.DE Yearly Net Income VS EBIT VS OCF VS FCFSHL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.83%, SHL is in the better half of the industry, outperforming 66.13% of the companies in the same industry.
SHL has a better Return On Equity (11.88%) than 69.35% of its industry peers.
SHL has a better Return On Invested Capital (7.65%) than 62.90% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 9.74%.
The last Return On Invested Capital (7.65%) for SHL is above the 3 year average (6.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROIC 7.65%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
SHL.DE Yearly ROA, ROE, ROICSHL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

The Profit Margin of SHL (9.17%) is better than 67.74% of its industry peers.
In the last couple of years the Profit Margin of SHL has remained more or less at the same level.
SHL's Operating Margin of 13.53% is fine compared to the rest of the industry. SHL outperforms 64.52% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
SHL has a Gross Margin of 38.63%. This is in the lower half of the industry: SHL underperforms 77.42% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
SHL.DE Yearly Profit, Operating, Gross MarginsSHL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
The number of shares outstanding for SHL has been reduced compared to 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
The debt/assets ratio for SHL has been reduced compared to a year ago.
SHL.DE Yearly Shares OutstandingSHL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SHL.DE Yearly Total Debt VS Total AssetsSHL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.05 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.05, SHL perfoms like the industry average, outperforming 45.16% of the companies in the same industry.
The Debt to FCF ratio of SHL is 5.45, which is a neutral value as it means it would take SHL, 5.45 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.45, SHL perfoms like the industry average, outperforming 53.23% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of SHL (0.63) is worse than 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Altman-Z 2.05
ROIC/WACC1.22
WACC6.25%
SHL.DE Yearly LT Debt VS Equity VS FCFSHL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

SHL has a Current Ratio of 1.11. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL has a Current ratio of 1.11. This is in the lower half of the industry: SHL underperforms 70.97% of its industry peers.
SHL has a Quick Ratio of 1.11. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.79, SHL is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.79
SHL.DE Yearly Current Assets VS Current LiabilitesSHL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. Growth

3.1 Past

SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
SHL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.29% yearly.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.08% yearly.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%

3.2 Future

SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
The Revenue is expected to grow by 5.85% on average over the next years.
EPS Next Y-0.32%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
EPS Next 5Y8.79%
Revenue Next Year2.83%
Revenue Next 2Y4.53%
Revenue Next 3Y5.13%
Revenue Next 5Y5.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHL.DE Yearly Revenue VS EstimatesSHL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
SHL.DE Yearly EPS VS EstimatesSHL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.79, which indicates a rather expensive current valuation of SHL.
Based on the Price/Earnings ratio, SHL is valued cheaper than 83.87% of the companies in the same industry.
SHL is valuated rather cheaply when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 18.86 indicates a rather expensive valuation of SHL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 64.52% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SHL to the average of the S&P500 Index (23.40), we can say SHL is valued inline with the index average.
Industry RankSector Rank
PE 18.79
Fwd PE 18.86
SHL.DE Price Earnings VS Forward Price EarningsSHL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 64.52% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 83.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.67
EV/EBITDA 13.98
SHL.DE Per share dataSHL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.66
EPS Next 2Y6.49%
EPS Next 3Y8.77%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.25%, SHL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.11, SHL pays a better dividend. On top of this SHL pays more dividend than 80.65% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, SHL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years0
Div Non Decr Years6
SHL.DE Yearly Dividends per shareSHL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

49.72% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.72%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
SHL.DE Yearly Income VS Free CF VS DividendSHL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SHL.DE Dividend Payout.SHL.DE Dividend Payout, showing the Payout Ratio.SHL.DE Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

FRA:SHL (12/30/2025, 2:06:15 PM)

44.92

+0.24 (+0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-05 2026-02-05
Inst Owners12.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap50.67B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts80
Price Target56.61 (26.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-1.06%
PT rev (3m)-8.52%
EPS NQ rev (1m)-1.14%
EPS NQ rev (3m)-10.29%
EPS NY rev (1m)-6.65%
EPS NY rev (3m)-8.85%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)1.58%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 18.79
Fwd PE 18.86
P/S 2.17
P/FCF 18.67
P/OCF 14.35
P/B 2.81
P/tB N/A
EV/EBITDA 13.98
EPS(TTM)2.39
EY5.32%
EPS(NY)2.38
Fwd EY5.3%
FCF(TTM)2.41
FCFY5.36%
OCF(TTM)3.13
OCFY6.97%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)N/A
PEG (5Y)1.66
Graham Number29.33
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROCE 9.97%
ROIC 7.65%
ROICexc 8.31%
ROICexgc 43.54%
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
FCFM 11.61%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Debt/EBITDA 2.54
Cap/Depr 63.12%
Cap/Sales 3.5%
Interest Coverage 7.04
Cash Conversion 79.23%
Profit Quality 126.59%
Current Ratio 1.11
Quick Ratio 0.79
Altman-Z 2.05
F-Score8
WACC6.25%
ROIC/WACC1.22
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y-0.32%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
EPS Next 5Y8.79%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year2.83%
Revenue Next 2Y4.53%
Revenue Next 3Y5.13%
Revenue Next 5Y5.85%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year34.58%
EBIT Next 3Y17.72%
EBIT Next 5Y14.23%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%

SIEMENS HEALTHINEERS AG / SHL.DE FAQ

What is the fundamental rating for SHL stock?

ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.


What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SIEMENS HEALTHINEERS AG?

SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SHL stock?

The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 18.79 and the Price/Book (PB) ratio is 2.81.


Can you provide the dividend sustainability for SHL stock?

The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.